Delivery Order SPE2DB25D3005-SPE2DB25FQFJF
Award Date
5/21/25
Potential Completion Date
5/22/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Alfuzosin HCL ER 10 mg tablets. The order is for $3,846.82 and has a firm fixed price. The contract has an ultimate completion date of September 12, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range of...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,569.81 contract is for the delivery of 120 tablets of the medication Alfuzosin HCl ER 10 mg. This award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,671.08 for the supply of 4,563,933,249 units of the prescription drug Alfuzosin HCl ER 10 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a firm fixed-price, open-competition delivery order with no set-aside designation. It has an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds a significant...
This contract award for $1,415.85 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Alfuzosin HCL ER 10 mg tablets and has an ultimate completion date of October 13, 2023. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a $11,307.61 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Alfuzosin HCL ER 10 mg tablets. The award is not a set-aside contract. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,788.12 firm fixed-price delivery order is for the supply of 4,565,550,860 units of the medication Alfuzosin HCL ER 10 mg tablets, with an ultimate completion date of August 23, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,142.46 firm-fixed-price delivery order is for the supply of Alfuzosin HCl ER 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. There was no set-aside designation for this contract....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,750.82 firm fixed-price contract is for the delivery of various pharmaceutical products and medical supplies, including prescription medications, medical devices, specialty pharmaceuticals, vaccines, syringes, and other healthcare-related items. The contract has an ultimate completion date of May 6, 2025 and is not...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The firm-fixed-price contract has a ceiling value of $9,635.30 and a performance period through May 2025. The contract is not set aside and is for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $27,824.04, is for the supply of various pharmaceutical products and medical supplies to federal agencies, particularly the military and veteran healthcare systems. The contract has a performance period through May 2025 and is a firm fixed-price delivery order, with no set-aside designation....